Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life sciences companies across the Midwest. The goal of the Fund is to provide investors with superior financial returns by making equity investments in innovative life sciences companies with sustainable and outstanding growth potential.

We take our name, Apjohn, from the original family name of one of our founders. The use of this family name reflects our desire to inspire life sciences entrepreneurs to build pharmaceutical successes much like Dr. William E. Upjohn did at the turn of the last century.

We welcome you to our web site and invite you to learn more about Apjohn Ventures.
News

4.4.2008
Asterand plc Announces Preliminary Results for 2007

3.19.2008
ProNAi Cleared to Begin Phase I Clinical Trials

4.4.2007
ITI Appoints Pharmaceutical Industry Veteran, Peter F. Young, as President and CEO

10.7.2005
Angiotech Completes Acquisition of Afmedica

Apjohn Ventures  :   269-349-8999  :   350 E. Michigan Avenue  :   Suite 500  :   Kalamazoo  :   Michigan  :   49007